Minnesota's Department of Health just released the latest results of its triennial Minnesota Student Survey, and the headline reads like a prohibitionist's nightmare: there has been a 57.7 percent statewide drop in self-reported past-year cannabis use from 2013 to 2025 among 8th, 9th, and 11th graders combined. "96 percent of students report not having used cannabis in the last month," the department said in its release. Gov. Tim Walz legalized adult-use cannabis in 2023, making this the first survey cycle conducted since the state ended prohibition.

She ordered from 10 seed banks over two years. Spent $1,000 of her own money. Tracked three things — germination rates, shipping reliability, and genetics quality — and wrote it all up without monetizing a single word of it. No affiliate links buried in the copy. No sponsored sections dressed up as opinions. Just notes from someone who got tired of hitting the same recycled listicles every time she searched "best seed banks" and decided to build the resource herself.

Per the White House's own fact sheet, the executive order does several things. It directs the FDA Commissioner to issue National Priority Vouchers to psychedelic drugs that have already received Breakthrough Therapy designation, which is meant to speed up the review process.

Rescheduling cannabis to Schedule III isn’t the goal, and our work isn’t done yet. Yet, it finally cracks open a nearly ancient framework and makes way for potentially revolutionary healthcare science grounded in research while also legitimizing cannabis as medicine. We no longer have to wonder when cannabis policy will evolve; it’s now a question of when society and institutions around us will finally catch on.

Let's get one thing straight before the spin machine buries it: the federal rescheduling of cannabis from Schedule I to Schedule III did not happen because Donald Trump had a change of heart about the plant. He didn't wake up one morning with a profound respect for the 50-year fight cannabis advocates have waged against the federal government.

Based on the researchers’ findings, individuals who consumed cannabis drinks reduced alcohol intake by nearly half, and they also decreased their binge drinking tendencies. They believe that cannabis drinks have the ability to replicate alcohol’s social experience, such as being able to drink it at social events without actually drinking booze.

Here we are in 2026, and a conflict that was supposed to wrap up in six weeks is entering its seventh with no visible exit strategy. The Strait of Hormuz — through which roughly 20-21% of the world's oil flows — is now effectively a choke point in a standoff that benefits defense contractors, arms dealers, and oil speculators while regular people pay the price at the pump and at the grave.

Based on the ruling, products that are legal federally as well as at the state level can be reimbursed, which is a huge step forward, given that older policies prevented all cannabis-based substances from being reimbursed by insurance. However, we must be careful to take note of the nuances here; the ruling doesn’t treat cannabis as a primary medical treatment just yet but rather they are considered “specialized, non-primarily health-related benefits” by the Centers for Medicare and Medicaid Services (CMS).

We understand: a huge part of why people are turning to AI for medical advice is because it’s just so accessible. But more importantly, especially in the field of medical marijuana, obtaining formal medical advice can be very difficult. More than that, there is still the stigma that we have to deal with, and oftentimes, many medical marijuana patients feel dismissed by traditional healthcare.

Read it carefully and you'll find something remarkable — not alarm, not moral panic, but a measured, almost bored scientific assessment. Dr. W.W. Stockberger of the Bureau of Plant Industry told the publication there was "no reason to become excited about a sporadic outbreak of hasheesh addiction." Hemp had been growing wild across America for years. Workers labored in hemp fields their whole lives and "never became addicts." Cannabis had a "large and legitimate use in veterinary medicine." It grew wild from the Atlantic coast to the Western plains. It was, in the view of the government's own plant scientists, a weed.

There's a specific kind of credibility that only comes from the inside. When cannabis advocates say the Controlled Substances Act is a broken instrument of policy failure, it gets filed under "predictable." When a former senior DEA official writes the same thing in a peer-reviewed paper published in Science, it lands differently.

If you find this surprising, you haven't been paying close enough attention to what cannabis has always been in this country. It has never been about public health. It has never been about safety. It has been a political lever, pulled by whoever is in power, against whoever they need to target.

High-quality THCA flower represents one of the more interesting developments in the hemp space right now. For those who want a whole-plant, minimally processed cannabinoid experience, it offers real appeal.

Cannabis edibles occupy a genuinely interesting place in modern wellness culture. They offer a smoke-free, longer-lasting, and increasingly well-understood way to experience the potential benefits of cannabinoids. Whether you are drawn to CBD for its calming properties, intrigued by the gentler profile of Delta 8, or simply looking to support better sleep and recovery, edibles give you a controllable, consistent format to work with.

Advanced cannabis products give medical patients tools that simply did not exist a decade ago. From terpene-rich live resin to precise tinctures and targeted topicals, the options available today reflect a maturing industry focused on quality and patient experience.

Consistent cannabis quality is not a luxury for medical users. It is a fundamental part of getting reliable results. From accurate cannabinoid labeling to clean growing practices and proper storage, every detail in the supply chain contributes to whether a patient's experience is positive or frustrating.

In 2021, Mexico's Supreme Court declared cannabis prohibition unconstitutional, setting the stage for full legalization. Then Congress proceeded to do absolutely nothing with that ruling for years. The legislative process stalled, got punted, stalled again. So what Mexico ended up with is a patchwork legal reality where your rights exist on paper but the infrastructure to exercise them barely exists at all.

Many students, bloggers, office workers, and content writers face this same issue. Paraphrasing looks simple from the outside, but when we sit down to write, the mind sometimes gives the same sentence again and again. The good thing is that you can improve this skill fast with daily practice, clear thinking, and a simple writing method.

The United States Army just quietly removed one of its longest-standing barriers to enlistment. Recruits with a marijuana-related conviction were previously required to undergo a two-year waiting period, seek a special Pentagon waiver, and pass a drug test. Those restrictions have now been dropped for anyone with a single conviction for possessing marijuana or marijuana-related paraphernalia.

The growth medium is typically agar-based — yes, the same substance used in microbiology to grow bacterial cultures — infused with a formulation derived from something called Murashige and Skoog (MS) salts, a nutrient mixture developed in the 1960s that has become the foundation of plant tissue culture worldwide. To this base, you add specific plant hormones: cytokinins to promote shoot proliferation, auxins to promote rooting, and various other compounds depending on what growth stage you are trying to achieve.

So when the Lancet team searched databases for RCTs treating mental disorders with cannabis as the primary treatment, they found a sparse pool — and then concluded the sparse pool means cannabis doesn't work. That conclusion is circular. You can't run a rigorous trial with plant material you can barely access, in the doses people actually use, then fault the plant for the absence of results.

Nixon was a law-and-order president who weaponized federal agencies against political enemies, escalated a war he inherited, used moral panic to consolidate power, and ran a domestic drug policy built more on politics than pharmacology. He resigned in disgrace. Trump in his second term is operating in an eerily similar register. The rhetoric around drugs — fentanyl, the border, cartel activity — has been maximalist and deliberately inflammatory.

While we’re right about inflammation, we’re looking at the wrong place: the root of the problem actually lies in the fascia, not isolated in the joints or muscles. We then considered treatment options that only addressed these parts of the body, offering localized pain relief. We thought that if we stretch or knead muscles enough, and strengthen them through regular exercise, we can reduce inflammation and pain.

The New York Times flipped on cannabis last month. We covered that. Filed it, sourced it, called it what it was — institutional cowardice dressed as public health journalism. Then this week, the Wall Street Journal ran its version. AOL pushed its version. The same week. Different mastheads, same message.

There are still some major roadblocks we have to overcome, such as the federal rescheduling of cannabis, and further education of physicians and doctors in cannabinoid therapeutics. Right now, many nurses and doctors still don’t feel confident enough to discuss cannabis with patients because of the lack of training. After all, cannabis wasn’t taught in school.

The engine is Gen Z. Analytics firm Headset found that over the past year of national cannabis sales, Gen Z spent 38% of their dollars on vapor pens and only 32.5% on flower — the exact inverse of Millennials, who put 40% into flower and 25.7% into vapes. Gen Z is also the first cannabis-consuming generation to prefer the cart over everything else as their primary format.

What it became is one of the most consequential cannabis-related cases the Supreme Court has ever heard — sitting at the crossroads of the Second Amendment, federal drug law, and the legal fiction that cannabis users are inherently dangerous people who can't be trusted with firearms.

On February 9th, 2026, the New York Times editorial board published a piece titled "It's Time for America to Admit That It Has a Marijuana Problem." I read it. I read it again. I sat with my coffee and I thought: after fifty years of calling cannabis a dangerous drug, after helping architect the moral panic that sent millions of people to prison for a plant, after cheerleading a drug war that killed tens of thousands and enriched criminal organizations across two continents — the Times has decided the problem with marijuana is that people are using too much of it.

"The War on Drugs" is a 12-track musical history project chronicling America's century-long crusade against psychoactive substances — told through music, lyrics, and the kind of receipts that don't get taught in school. Each track corresponds to a specific era, a specific truth, and a specific act of institutional theater dressed up as public health policy.

Yesterday — as in literally 24 hours ago as I write this — Texas Democratic primary voters approved a ballot question asking whether the state should legalize cannabis for adults and automatically expunge criminal records for past low-level offenses. They approved it by 80% to 20%. With 92% of polling locations reporting.

This is the apocalypse we actually got — not the dramatic cinematic one with the mushroom clouds and the clear enemy and the hero's journey. The slow one. The one where the institutions keep functioning just enough to maintain plausible deniability while clearly not functioning at all. The one where you can't tell if you're witnessing the birth of tyranny or just a very bad few years. The one where the elites keep doing elite things and everyone is slowly losing their mind trying to decide how seriously to take all of it.

The enemy changes—communists, terrorists, witches, heretics, the other political party—but the mechanism remains the same. Polarization. The deliberate construction of an "us vs. them" narrative that reduces complex human beings into simplistic categories: good or evil, patriot or traitor, with us or against us. This isn't politics. This is social engineering.

A sudden, simultaneous substitution of fentanyl with nitazenes across the entire supply chain would trigger immediate pattern recognition — a spike in overdose deaths so dramatic that it would generate emergency federal response within days. The military framing would become unavoidable. The political will to respond would crystallize quickly.

Over the past few years, THCa flower has become one of the most discussed categories in cannabis. As consumers across the United States search for alternatives to traditional dispensary markets, many people are discovering that hemp-derived cannabis products have opened the door to a new kind of accessibility.

In the first piece, I argued that the United States is losing a chemical war with China, and that the only asymmetric counter-strategy with any historical precedent for success is domesticating the drug supply — legalizing the agrarian, organic substances that humans have used for millennia, regulating them intelligently, and stripping the cartels of their customer base through market competition.

Yale University is one of the pioneering institutions in psilocybin research. So much so that they have their own multidisciplinary program dedicated to studying the effects of psychedelic agents and their therapeutic potential. They are currently running several psilocybin clinical trials, to better learn about its effects on various aspects of mental health, including obsessive-compulsive disorder, major depressive disorder, post-traumatic headaches, and cluster headaches,among others.

Here's something that should fundamentally change how we think about autism and cannabis: autistic children have significantly reduced plasma levels of endocannabinoids. The endocannabinoid system (ECS) is a ubiquitous neuromodulatory network that regulates socioemotional responses, cognition, seizure susceptibility, pain perception, and neuronal plasticity. In other words, it governs precisely the areas where autistic individuals struggle most.

The pharmacological difference between natural THC and synthetic cannabinoids like K2 is the difference between a partial agonist and a full agonist. THC, the active compound in cannabis, partially activates the CB1 receptor in your brain. There is a biological ceiling on how activated that receptor can get from natural cannabis. This is why a fatal marijuana overdose is, for all practical purposes, impossible.

Here's the reality that gets buried under every sensationalized headline about "marijuana-induced madness": the baseline annual incidence of psychotic disorders in the general population is approximately 0.0027%. That's 2.7 cases per 100,000 people. You have better odds of being struck by lightning. Now, when we factor in cannabis use, even among daily users of high-potency products, that risk climbs to somewhere between 0.008% and 0.011% annually. Over a ten-year period, we're talking about a cumulative risk of 0.08% to 0.11%.

Enter a recent study from the Learned Societies Trust that asks: "Can taxation be used to effectively limit young people's use of legalized marijuana?" The research, conducted by Michelle Sovinsky, observes that young people tend to use marijuana, alcohol, and cigarettes in combination. The conclusion? If we increase taxes on alcohol and cigarettes, we can reduce marijuana use among youth.

There are moments in media that cut through the bullshit so cleanly, you can actually hear the narrative collapse in real-time. Combat veteran Staff Sergeant (Ret.) Johnny "Joey" Jones just delivered one of those moments on Fox News—and the network's desperate attempt to spin it back into prohibitionist talking points was almost as revealing as Jones' truth bombs.

Congressman Andy Harris just told you exactly what Schedule III rescheduling is: a 20-year stalling tactic designed to run out the clock on marijuana legalization. He said the quiet part out loud, and we should thank him for the honesty. This isn't about science. It isn't about safety. It isn't about protecting children or public health or any of the other rhetorical bullshit they've been feeding us for 87 years.

According to a study conducted by researchers at the University of Massachusetts at Amherst, together with Johns Hopkins University’s Bloomberg School of Public Health, public schools in Massachusetts saw a downward trend in marijuana-related disciplinary issues. After Massachusetts legalized recreational cannabis, consumption of the drug among teens dropped 25%, based on data from the Massachusetts Youth Risk Behavior Survey.

The New York Times wants you to believe America has a marijuana problem. I want you to believe the New York Times has an integrity problem. In February 2026, the editorial board of what's supposedly America's "paper of record" published a breathtaking reversal of their decade-old position on cannabis legalization. The headline might as well have been written by Kevin Sabet himself: essentially declaring that marijuana legalization was a "mistake" requiring "sober reassessment."

In another study, researchers in Germany found that orally administering THC was associated with improved survival times among terminally ill patients. Investigators analyzed the effects of cannabis-based medications and patient survival times among individuals registered in the Specialized Palliative Outpatient Care (SAPV) department.

A practical online head shop buyer’s guide covering quality, reviews, bongs, dab rigs, vaporizers, and what really matters when shopping for cannabis gear online.

Hemp and marijuana are the same plant. Scientifically, legally, botanically—it's all Cannabis sativa L. The only difference is an arbitrary legal threshold of 0.3% delta-9 THC content. Below that line? Legal hemp. Above it? Schedule I controlled substance, sitting right next to heroin.

There are serious, long-lasting implications for the US leaving the World Health Organization, including potential consequences for medical marijuana, the future of cannabis reform, and drug policy as a whole.

A recent study published in the journal Clinical Pharmacology and Therapeutics is challenging this long-held belief. Contrary to popular opinion, the research suggests that CBD may actually intensify the effects of THC, not dampen them. This revelation is sending ripples through the cannabis community and forcing us to reconsider our understanding of how these cannabinoids interact.

A recent study published in the International Journal of Drug Policy examined the drinking habits of cannabis beverage consumers and found something the alcohol industry has been dreading for years—people who consume THC-infused drinks report significant reductions in their alcohol consumption. We're not talking about a negligible dip. We're talking about people actively substituting a non-toxic, non-addictive substance (cannabis) for one of the most dangerous drugs legally available (alcohol).